Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01228058 · ClinicalTrials.gov registry record
A Prospective Evaluation of Thromboelastography for Identifying Coagulopathy in Severely Injured Patients
A clinical trial, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- 1,450
- Enrollment target
NCT01228058: Completed study, sponsored by The University of Texas Health Science Center, Houston.
NCT01228058 is a clinical trial that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 1,450 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01228058 has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- 1,450 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the clinical utility of thrombelastography (TEG) to predict and identify trauma patients at increased risk of receiving blood transfusion, develop multiple organ failure and mortality. TEG has been proposed as a superior tool to rapidly diagnose and help guide resuscitation with blood products and preclinical data suggest that TEG is both more sensitive and specific than PT or PTT for coagulation abnormalities. Based on the preclinical work led by Dr. Holcomb, our hypothesis is that the Rapid TEG will help to identify these coagulopathic patients earlier, allow for rapid MT protocol activation, and assist in developing data driven blood product transfusion guidelines.
Interventions
- PROCEDURE RapidTEG test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,450 participants |
| Start Date | 2010-11 |
| Est. Completion | 2012-01 |
What the finished NCT01228058 record still lists
NCT01228058 is an observational study that tracks outcomes without assigning an intervention. Its 1,450 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which RapidTEG test is the first listed.
NCT01228058 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01228058 about?
NCT01228058 is a clinical study titled "A Prospective Evaluation of Thromboelastography for Identifying Coagulopathy in Severely Injured Patients". The purpose of this study is to evaluate the clinical utility of thrombelastography (TEG) to predict and identify trauma patients at increased risk of receiving blood transfusion, develop multiple organ failure and mortality. TEG has been proposed as a superior tool to rapidly diagnose and help gui...
What is the current status of trial NCT01228058?
This trial is currently completed. The enrollment target is 1,450 participants. The study started on 2010-11. Estimated completion is 2012-01.
What interventions are being tested in trial NCT01228058?
The interventions under investigation include: RapidTEG test (PROCEDURE).
Who is sponsoring clinical trial NCT01228058?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04566328 · 1,450 participants · Phase 3
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
- NCT05229341 · 1,450 participants · NA
Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules
- NCT05910268 · 1,450 participants · NA
Peru Decentralized HIV Care
- NCT06305312 · 1,450 participants · NA
Community Services Navigation to Advance Health Equity in Breast Cancer Screening
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia